News

generic prostate - Copied 23/09/2019 11:12

What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?

12 August 2026
A randomised trial evaluating Bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update - resized_w123.jpg

Melanoma treatment mystery gets new answers

12 August 2026
baby

New study suggests genomic newborn screening could identify some children at risk for early cancers

12 August 2026
characteristics of patients with hepatocellular carcinoma in Madagascar

Liver cancer experts co-author new treatment framework for hepatocellular carcinoma

12 August 2026
Pollution

Study uncovers pre-cancerous link between air pollution exposure and lung cancer risk

12 August 2026
 Triple-negative breast cancer subtypes identified using microRNA  - 3789.jpg

Can mini organs help predict breast tumours’ response to therapy

12 August 2026
generic lab research study cropped

Trk and IGF1R-related signaling linked to delayed Ewing sarcoma growth

11 August 2026
prostate

Study finds traditional prostate cancer risk factors do not predict hormone therapy benefit

11 August 2026
blood

Researchers identify an 'energy addiction' in high-risk blood cancer stem cells

11 August 2026
A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer - resized_Picture 1.jpg

Where women live may influence ovarian cancer survival, especially among Black women

11 August 2026
AML

Immune cells in bone marrow cancer: limited defense readiness

11 August 2026
head and neck cancer

Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy

11 August 2026
Back to Top